NVO - Novo Nordisk A/S

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts2233
Avg. Estimate0.670.682.73
Low estimate0.630.672.572.9
High estimate0.70.72.773.09
Year ago EPS0.610.642.462.7
Revenue estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts2233
Avg. Estimate4.73B4.83B19.63B20.82B
Low estimate4.58B4.79B19.36B20.59B
High estimate4.87B4.87B19.78B21.19B
Year ago sales4.52B4.54B18.29B19.63B
Sales growth (year/est)4.60%6.30%7.30%6.10%
Earnings history29/06/201929/09/201930/12/201930/03/2020
Est. EPS0.610.620.550.68
Actual EPS0.610.640.550.75
Difference00.0200.07
Surprise %0.00%3.20%0.00%10.30%
EPS trendCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Current estimate0.670.682.73
7 days ago0.660.682.683
30 days ago0.660.692.692.96
60 days ago0.680.72.642.76
90 days ago0.680.72.642.78
EPS revisionsCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A1N/A1
Growth estimatesNVOIndustrySector(s)S&P 500
Current qtr.9.80%N/AN/AN/A
Next qtr.6.30%N/AN/AN/A
Current year9.80%N/AN/AN/A
Next year11.10%N/AN/AN/A
Next 5 years (per annum)9.80%N/AN/AN/A
Past 5 years (per annum)5.69%N/AN/AN/A
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more